Human Radiolabeled Mass Balance Studies Supporting New Drugs Approved by FDA Between 2019 and 2023. [PDF]
Ramamoorthy A +9 more
europepmc +1 more source
Development of NOTA-based antibody-fragment labeling agent that reduces early renal radioactivity levels. [PDF]
Katamoto S +6 more
europepmc +1 more source
Natural radionuclide measurement and radioactivity assessment of soil samples in Gansu Province (China). [PDF]
Wang F +9 more
europepmc +1 more source
Tumour SUVmean and volume relates to its radiation absorbed dose. [PDF]
Kao YH.
europepmc +1 more source
First-in-Human, Open-label, Single-Arm Phase I Study of [211At] meta-Astatobenzylguanidine in Patients with Pheochromocytoma or Paraganglioma. [PDF]
Okamoto S +11 more
europepmc +1 more source
Isotope analyses of the lake sediments in the Plitvice Lakes, Croatia
Horvatinčić Nada +7 more
doaj +1 more source
Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement. [PDF]
Chaib S +6 more
europepmc +1 more source
Therapeutic Efficacy and Safety of Intraperitoneally Administered <sup>211</sup>At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies. [PDF]
Kato H +11 more
europepmc +1 more source
Auger Electron Therapy Enhanced by Heat-Triggered Release of I-125-Labeled DNA-Targeted Compounds within the Tumor Microenvironment. [PDF]
Munekane M +6 more
europepmc +1 more source
Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics. [PDF]
Avrov KO +9 more
europepmc +1 more source

